- Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
- Browse: 218 Download: 419 Issue Date: 2024-10-21
- Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study
- Browse: 203 Download: 439 Issue Date: 2024-10-21
- False occult hepatitis B infection with negative hepatitis B surface antigen while positive hepatitis B envelope antigen: A case report
- Browse: 170 Download: 484 Issue Date: 2024-10-21
- Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
- Browse: 196 Download: 331 Issue Date: 2024-10-21
- Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
- Browse: 173 Download: 414 Issue Date: 2024-10-21
- Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
- Browse: 134 Download: 429 Issue Date: 2024-09-23
- Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
- Browse: 157 Download: 435 Issue Date: 2024-09-23
- Immune remodulation in pediatric inherited metabolic liver diseases
- Browse: 143 Download: 376 Issue Date: 2024-09-23
- Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
- Browse: 148 Download: 437 Issue Date: 2024-09-23
- Kick-start for metabolomics in liver disease
- Browse: 153 Download: 370 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 176 Download: 413 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 212 Download: 443 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 199 Download: 384 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 177 Download: 287 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 148 Download: 327 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 269 Download: 521 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 288 Download: 583 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 266 Download: 457 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 283 Download: 551 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 321 Download: 465 Issue Date: 2024-07-26